Application 209717
- Type
- ANDA
- Sponsor
- AMNEAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 100MG BASE | No | No |
| 002 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 150MG BASE | No | No |
| 003 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 200MG BASE | No | No |
| 004 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 300MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209717-001 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2020-06-01 | ||
| A209717-002 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-01 | ||
| A209717-003 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-01 | ||
| A209717-004 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209717-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2020-06-01 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209717-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209717-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209717-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209717-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2020-06-01 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209717-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-01 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209717-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-01 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209717-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-01 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209717-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2020-06-01 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209717-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-01 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209717-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-01 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209717-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-01 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209717-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2020-06-01 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209717-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209717-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209717-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209717-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2020-06-01 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209717-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209717-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209717-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209717-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2020-06-01 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209717-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209717-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209717-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209717-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2020-06-01 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A209717-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209717-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209717-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209717-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2020-06-01 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209717-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209717-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209717-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209717-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2020-06-01 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A209717-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209717-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209717-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209717-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2020-06-01 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A209717-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209717-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209717-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2020-06-01 | 4b0b4de00fa7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209717-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209717-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209717-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209717-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209717-003 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209717-004 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209717-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209717-003 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209717-004 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209717-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209717-003 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209717-004 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209717-002 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A209717-003 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A209717-004 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209717-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209717-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209717-004 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A209717-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A209717-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A209717-004 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A209717-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A209717-003 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A209717-004 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A209717-002 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A209717-003 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A209717-004 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A209717-002 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A209717-003 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A209717-004 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209717-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209717-003 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209717-004 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A209717-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A209717-003 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A209717-004 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A209717-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A209717-003 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A209717-004 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A209717-002 | AB | 1 | c0c555d07b60… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atazanavir Sulfate | ATAZANAVIR | Aurobindo Pharma Limited | 7fbea274-d6b5-4faa-bbf0-05fefab42114 | 2025-08-06 | Warnings, Adverse reactions | Atazanavir Sulfate |
| Atazanavir Sulfate | ATAZANAVIR SULFATE | Teva Pharmaceuticals USA, Inc. | 654b7e08-33d8-47e7-b37f-3681e79c7b8b | 2024-12-30 | Warnings, Adverse reactions | Atazanavir Sulfate ATAZANAVIR SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69238-1135 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1135 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1135 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1136 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1136 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1136 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1137 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1137 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1137 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1138 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1138 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1138 | Atazanavir | Atazanavir | Amneal Pharmaceuticals NY LLC | ANDA | Current |